Daily Brief Thematic (Sector/Industry): Smartkarma Webinar | China EVs: Sales Strong and more

In our next Webinar, we welcome Analysts Chris Redl (SC Capital) and Sameer Taneja (Investics Research), who will be joined by Smartkarma CEO Raghav Kapoor in an exciting discussion on the EV landscape in China.

The webinar will be hosted on Friday, 21 October 2022, 11:00 SGT/HKT.

Chris Redl has over 20 years’ experience covering the global automotive industry both on the Sell-side (UBS & Morgan Stanley) and Buy-side (Och-Ziff). His current focus is on electric vehicle stocks & their supply chains, aiming is to identify the winners and losers from a long/short perspective. This includes close coverage of legacy automakers as well.

Sameer Taneja is the founder of Investics Research, a firm that engages in bottom-up sectoral research, fundamental research of publicly listed companies as well as forensic analysis. He started his career as a sell-side analyst in a stockbroking firm called B&K Securities (India) from 2004-07, covering the ferrous sector. From 2007-16 he worked as an investment analyst in a hedge fund called Kelusa Capital, covering the materials, utilities, construction & heavy machinery, and the auto sector. He continued to work on the buy-side from 2017-19 in a firm called Skale Investments (with similar sectoral coverage), before founding Investics Research in 2019.

Raghav is the co-founder and CEO of Smartkarma.

• The Ministry of Health Labor and Welfare is likely to allow funds transfer service providers (cashless apps) to support digital salary payments 
• That could boost user and transaction volume growth rates although there are challenges like remittance limits and direct access to cash that need to be addressed
• An expansion in utility is positive although comparable valuations from global peers remains under pressure

• Occupancy rate is improving on the cost of rental rate When Covid-19 restrictions were imposed,work from home was the only solution for companies in Bangkok to continue their operations in2020-2021
• FY3Q22 (End June 22) result slightly rose QoQ 2Q22 net profit surged to Bt114m (6 times YoY,4 times QoQ) mainly due to asset revaluation.Excluding the unrealized gains of Bt87m, 2Q22 
• LHPF (NR)is poised for growth and has cheap valuation The occupancy rate had bottomed out in 2Q20 and is increasing continuously from there while the rental rates have fallen significantly

• The recent rally in healthcare is mainly driven by medical device sector. But investors are advised to exit in time before the truth is revealed.
• For pharmaceutical sector, it may not be as lucky as medical device sector.Even if it has followed the positive momentum of medical device sector, stock price would diverge after that.
• We won’t take any chances on CXO due to geographical conflicts and overseas policy risks, with “no reversal signal”. We updated our top picks in various sectors. 

• The EU traditionally imported a large number of intermediate goods from China, however, as EU economies slow down, the slowing consumer demand will also reduce the demand for intermediate goods.
• EU’s manufacturers traditionally focus on high end, high margin products while China provides daily consumer products, the substitution effect is limited.
• China does have advantages in products such as textile, metallurgy and office communication supplies, the business case is subject to prevailing geopolitical factors.